APIs

Albemarle has a long history of supplying active pharmaceutical ingredients (APIs) for the ethical and generic pharmaceutical markets. Our APIs are manufactured in the USA, strictly adhering to the FDA’s cGMP requirements as proven by our excellent regulatory record. We support our customers with technical service and regulatory professionals who provide information and guidance as needed for efficient and effective use of our APIs.

In addition to our existing commercial products, Albemarle has an ongoing program to develop new APIs. We have a wide range of expertise and capabilities, ranging from small to large volume products for use in all forms of drug products including oral and injectable dosages.

The list below provides information about our commercial products as well as our advanced stage developmental products. Feel free to contact us for more information about these or our earlier stage developmental products.

Product name		CAS #	Status (Commerical, Developmental)	Contact us
Amifostine		20537-88-6	Commercial
Benazepril hydrochloride			Commercial
Benzonatate			Commercial
Diphenhydramine citrate			Commercial
Fenoprofen calcium			Commercial
Flurbiprofen			Commercial
Ibuprofen		15687-27-01	Commercial
Ibuprofen sodium		31121-93-4	Commercial
Itraconazole			Commercial
Ketoconazole			Commercial
Lidocaine hydrochloride			Commercial
Meclofenamate			Commercial
Milrinone			Commercial
Orphenadrine citrate			Commercial
Pramipexole		104632-26-0	Developmental
Procainamide hydrochloride			Commercial
Propofol (Europe)		2078-54-9	Commercial
Propofol (North America)		2078-54-8	Commercial
Propranolol hydrochloride			Commercial
Terconazole			Commercial
Tetracaine hydrochloride			Commercial
Tetrahydrozoline hydrochloride			Commercial
Verteporfin		129497-78-5	Developmental
Zoledronic acid		118072-93-8	Developmental